Target intelligence / Profile preview

SIINFEKL–H-2Kb peptide–MHC class I complex (SIINFEKL-H-2Kb)

Target
SIINFEKL-H-2Kb
Molecular classification
Major Histocompatibility Complex (MHC) class I, Antigen-presenting complex, Peptide-MHC complex
01

Overview

The SIINFEKL–H-2Kb peptide–MHC class I complex is a molecular assembly comprising the immunodominant peptide SIINFEKL (residues 257–264 of chicken ovalbumin) bound to the mouse H-2Kb MHC class I molecule (Fremont et al., 1992, Science). It is a fundamental tool in immunology for studying antigen presentation and CD8+ T-cell activation, particularly through the use of the OT-I transgenic mouse model which expresses a TCR specific for this complex (Hogquist et al., 1994, Cell). The complex is a target for TCR-like monoclonal antibodies, such as 25-D1.16, which are used to visualize and quantify specific antigen presentation on the cell surface (Porgador et al., 1997, Immunity). In preclinical research, it serves as a model target for developing CAR-T cells and vaccines aimed at inducing specific cytotoxic T lymphocyte (CTL) responses (Yosef et al., 2021, Front. Immunol.). While it is a mouse-specific system, it provides essential insights into the development of peptide-MHC-targeted therapies for human cancers and infectious diseases. The complex is also used to study the kinetics of peptide binding and the stability of MHC molecules (Janeway's Immunobiology, 9th Ed).

Other names
Ovalbumin (257-264) peptide-H-2Kb complexH-2Kb/SIINFEKLOVA-pMHCSIINFEKL-MHC class I complexH2-Kb-SIINFEKL
02

Mechanism of action

Specific recognition by T-cell receptors (TCRs) or TCR-like antibodies leads to the activation of cytotoxic T lymphocytes and subsequent lysis of the antigen-presenting cell.

03

Biological functions

Antigen presentationCD8+ T cell activationImmune surveillanceT cell epitope recognition
04

Disease associations

Cancer (preclinical models)Infection (preclinical models)Autoimmunity (preclinical models)
05

Safety considerations

Off-target cross-reactivity with endogenous peptidesMHC downregulation (immune escape)Species-specific relevance (limited to murine models)
06

Interacting drugs

25-D1.16 monoclonal antibody

2 more in the full profile.

07

Biomarkers

Surface expression of SIINFEKL-H-2Kb complex

Beyond the preview

Go deeper on SIINFEKL–H-2Kb peptide–MHC class I complex (SIINFEKL-H-2Kb).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SIINFEKL–H-2Kb peptide–MHC class I complex (SIINFEKL-H-2Kb).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call